Melanoma News and Research

Latest Melanoma News and Research

Einstein researchers awarded $2.6 million NIH grant to develop effective cancer immunotherapies

The National Institutes of Health has awarded two co-investigators at Albert Einstein College of Medicine a five-year, $2.6 million grant to make immunotherapy agents that more precisely and effectively treat a variety of cancers while causing far fewer side effects than current immunotherapies.

20 Oct 2016

SWAT team of immune cells linked to low infection rates after cleft lip and palate surgery in infants

The mouth is widely considered the dirtiest part of the human body, yet babies have surprisingly low infection rates following cleft lip and palate surgery.

18 Oct 2016

New OU photothermal therapy may eliminate tumors without affecting healthy cells in the body

A staggering 1.7 million persons in the United States will be diagnosed with cancer in 2016, with 600,000 cases ending in death. University of Oklahoma researchers have collaborated to design a novel, non-invasive cancer therapy that could eliminate tumors without affecting the healthy cells in the body.

18 Oct 2016

How could emerging technologies impact cancer care?

The major innovations in cancer diagnosis, therapy/palliative care and surgical intervention are too numerous to list here. But enormous strides have taken place in stem cell therapy, monoclonal antibody therapy and genetic screening.

17 Oct 2016

NAC improves effectiveness of adoptive cell therapy for treating melanoma

A collaborative team of investigators at the Medical University of South Carolina and Loyola University have demonstrated for the first time that culturing T cells in N-acetyl cysteine (NAC) before they are infused as immunotherapy improves effectiveness and outcomes in a preclinical model of melanoma. These findings were reported in the October 15, 2016 issue of Cancer Research.

17 Oct 2016

British Skin Foundation celebrates 20 years of research

Sixty percent of British people currently suffer from or have suffered from a skin disease at some point during their lifetime according to a new survey revealed at the British Skin Foundation’s Skin Deep – 20 Years of Research conference on 13th October in London.

14 Oct 2016

Houston Methodist researcher receives $4 million to create triple negative breast cancer immunotherapy

Scientists at Houston Methodist received support from the U.S. Department of Defense to reprogram cancer patients' immune cells to attack triple negative breast cancer, the most lethal form of breast cancer.

13 Oct 2016

CarThera receives €5.7 million grant for DOME project from France’s Investments for the Future Program

CarThera, which designs and develops innovative medical devices to treat brain disorders, today announces it has received a grant of €5.7 million ($6.4m) for its DOME project.

13 Oct 2016

Immune checkpoint inhibitor as adjuvant therapy improves overall survival in patients with stage III melanoma

Ipilimumab as adjuvant therapy significantly improves overall survival in patients with high risk stage III melanoma, according to the EORTC 18071 phase III trial results presented for the first time today at the ESMO 2016 Congress in Copenhagen.

8 Oct 2016

Added benefit not proven for melanoma drug, IQWiG finds

Talimogene laherparepvec has been approved since December 2015 for adults with advanced melanoma.

7 Oct 2016

Survey reveals inequalities in access to new, life saving drugs for melanoma in Europe

Over 5000 patients with metastatic melanoma in Europe are denied access to new, life saving drugs every year, according to a survey presented at the ESMO 2016 Congress in Copenhagen.

7 Oct 2016

Researchers report high response rate with single drug in phase I/II trial of paediatric brain cancer

A high response rate with a single drug in a phase I/II trial of paediatric brain tumour has set the stage for combination therapy with higher response and lower toxicity, researchers reported at the ESMO 2016 Congress in Copenhagen.

7 Oct 2016

Combination therapy for melanoma has added benefit in certain patients

Nivolumab in combination with ipilimumab has been approved since May 2016 for adults with advanced melanoma. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this drug offers an added benefit.

6 Oct 2016

NCCN publishes new resources to help patients understand treatment options for stomach cancer

This year, it is estimated that more than 26,000 people will be diagnosed with Stomach Cancer in the United States, with nearly one million new cases diagnosed worldwide each year.

4 Oct 2016

HPV vaccine can decrease incidence of cervical pre-cancers among young women, research shows

Every 20 minutes, someone in the United States receives a cancer diagnosis related to human papillomavirus. HPV causes cancer of the cervix, anus and throat.

29 Sep 2016

Combination of different drugs could improve effect of immunotherapy on skin cancer

The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center show that the effect of immunotherapy on malignant melanoma (black skin cancer) can be improved by combining it with other cancer treatments.

27 Sep 2016

SRS reduces likelihood of local recurrence of brain metastases in cancer patients

Stereotactic radiosurgery (SRS) for cancer patients who receive the treatment for brain metastases decreases the likelihood of local recurrence but shows no positive difference in terms of overall survival (OS) or distant brain metastases (DBMs) rates, when compared to observation alone following surgical resection of brain metastases, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

Mount Sinai and TJU researchers awarded grant for UM research

Uveal melanoma (UM) is the second most common type of skin cancer. Approximately 50 percent of patients will develop metastasis or spread of their cancer, most commonly to the liver.

21 Sep 2016

Immune and targeted therapies may be beneficial in patients with melanoma brain metastases

Brain metastases are one of the most common complications of advanced melanoma, requiring multidisciplinary management.

21 Sep 2016

Scientists use novel theranostics technique for early thromboembolism diagnosis and treatment

Researchers from the University of Arkansas for Medical Science (USA), in collaboration with University Hospital Frankfurt and University Hospital Dresden, under the supervision of Prof. Vladimir Zharov and with the participation of Alexander Melerzanov, the dean of Department of Biological and Medical Physics (MIPT), conducted experiments on mice to detect blood clotting using photoacoustic flow-cytometry.

21 Sep 2016

Melanoma News and Research

Latest Melanoma News and Research

Einstein researchers awarded $2.6 million NIH grant to develop effective cancer immunotherapies

SWAT team of immune cells linked to low infection rates after cleft lip and palate surgery in infants

New OU photothermal therapy may eliminate tumors without affecting healthy cells in the body

How could emerging technologies impact cancer care?

NAC improves effectiveness of adoptive cell therapy for treating melanoma

British Skin Foundation celebrates 20 years of research

Houston Methodist researcher receives $4 million to create triple negative breast cancer immunotherapy

CarThera receives €5.7 million grant for DOME project from France’s Investments for the Future Program

Immune checkpoint inhibitor as adjuvant therapy improves overall survival in patients with stage III melanoma

Added benefit not proven for melanoma drug, IQWiG finds

Survey reveals inequalities in access to new, life saving drugs for melanoma in Europe

Researchers report high response rate with single drug in phase I/II trial of paediatric brain cancer

Combination therapy for melanoma has added benefit in certain patients

NCCN publishes new resources to help patients understand treatment options for stomach cancer

HPV vaccine can decrease incidence of cervical pre-cancers among young women, research shows

Combination of different drugs could improve effect of immunotherapy on skin cancer

SRS reduces likelihood of local recurrence of brain metastases in cancer patients

Mount Sinai and TJU researchers awarded grant for UM research

Immune and targeted therapies may be beneficial in patients with melanoma brain metastases

Scientists use novel theranostics technique for early thromboembolism diagnosis and treatment

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Melanoma News and Research

Latest Melanoma News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in